ACIC manufactures, supplies and sources, on an exclusive basis, an extensive range of Active Pharmaceutical Ingredients from cGMP and FDA inspected manufacturers. With years of experience in the branded and generic pharmaceutical industry, ACIC continues to be very active in the development and contract manufacturing of small molecule API’s using both synthesis or fermentation processes.
Everyone knows the path from molecule to market. The challenge is to find the fastest and most efficient way. The ACIC approach is designed to help you arrive at the most efficient solutions by offering you a wide range of global choices.
ACIC has helped many different leading active ingredient manufacturers to gain access to world markets – especially the hard to penetrate U.S., Canadian, European, and Latin American markets.
ACIC also provides manufacturing partners with first-class sales and product representation, regulatory approval management, and DMF / eDMF / PR-DMF as well as NDA, ANDA (USA) and C.N.O.R. (Canada) and European documentation preparation including ongoing strategic marketing advice.
Some of the key Therapeutic Categories where ACIC is most active include:
- Oncology Biosimilars
- Protease Inhibitors